FFCP PHASE1:Hg19::chr2:192712167..192712178,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C104 | |||
|description=CAGE_peak_at_chr2:192712167..192712178,+ | |||
|id=chr2:192712167..192712178,+ | |||
|ontology_enrichment_celltype=CL:0002274!1.13e-30!5;CL:0000457!1.13e-30!5;CL:0002191!1.13e-30!5;CL:0000097!1.13e-30!5;CL:0000831!1.13e-30!5;CL:0002028!1.13e-30!5;CL:0000163!5.89e-17!9;CL:0001024!2.84e-07!1 | |||
|ontology_enrichment_celltype_v019=CL:0000097;1.50e-156;5!CL:0000163;1.37e-87;9!CL:0000151;1.30e-20;36!CL:0000766;2.86e-08;69 | |||
|ontology_enrichment_celltype_v019_2=CL:0000097,1.50e-156,5;CL:0002028,1.50e-156,5;CL:0000163,1.37e-87,9;CL:0000151,9.32e-23,36;CL:0000839,1.15e-12,66;CL:0000557,1.71e-12,67;CL:0000766,1.07e-11,72;CL:0000763,4.22e-08,108;CL:0000049,4.22e-08,108;CL:0002031,2.26e-07,120 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:3112!6.12e-07!1 | |||
|ontology_enrichment_disease_v019= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002106!1.39e-08!3;UBERON:0004854!1.39e-08!3;UBERON:0009034!1.39e-08!3;UBERON:0002095!1.39e-08!3;UBERON:0004782!1.39e-08!3;UBERON:0003281!1.39e-08!3;UBERON:0009664!1.39e-08!3;UBERON:0002296!1.39e-08!3;UBERON:0005602!1.39e-08!3;UBERON:0001179!1.39e-08!3;UBERON:0006293!1.39e-08!3;UBERON:0004177!9.30e-08!7;UBERON:0007029!1.98e-07!1;UBERON:0001154!3.20e-07!1;UBERON:0001153!3.20e-07!1;UBERON:0002581!9.73e-07!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002371,3.92e-11,76;UBERON:0001474,2.17e-10,82;UBERON:0004765,1.51e-09,90;UBERON:0002405,2.87e-09,93;UBERON:0002390,7.68e-09,98;UBERON:0003061,7.68e-09,98;UBERON:0001434,1.11e-08,100;UBERON:0002193,4.22e-08,108 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.293600439334847,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.255725123687061,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.198762407366705,0,0,0,0,0,0.208994966536811,0,0.35576626268671,0,0,0,0,0,0,0.0892997282840798,0,0,0,0,0.183201743930407,0,0,0,0,0,0.397227542439656,0,0,0,0,0,0,0,0,0.151357427644931,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0895585227028483,0,0,2.46331618947972,0.616339038092582,5.59785911960085,21.0415131988764,2.65109110195398,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.199579371432817,0.191505370132367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.276283915531148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0769502585037971,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.063186579628488,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.160753148465019,0,0,0,0,0,0,0,0,0,0,0.191915197319445,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213574825135389,0,0,0,0,0,0,0,0,0,0.327872630709804,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.308801447160972,0.219284049578707,0.176689145945881,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163771917510097,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0657727735628491,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.485710993059139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.281951753939561,0.128915775947154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.109265571963696,0,0,0,0,0,0,0,0,0,0,0,0,0.0620747142958579,0.33639558774184,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:192712167..192712178,+ | |||
}} |
Revision as of 07:39, 21 January 2014
Short description: | p@chr2:192712167..192712178, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr2:192712167..192712178, + |
Coexpression cluster: | C104_Mast_Basophils_immature_CD14_CD34_eye_Natural |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mast cell | 1.50e-156 | 5 |
basophil mast progenitor cell | 1.50e-156 | 5 |
endocrine cell | 1.37e-87 | 9 |
secretory cell | 9.32e-23 | 36 |
myeloid lineage restricted progenitor cell | 1.15e-12 | 66 |
granulocyte monocyte progenitor cell | 1.71e-12 | 67 |
myeloid leukocyte | 1.07e-11 | 72 |
myeloid cell | 4.22e-08 | 108 |
common myeloid progenitor | 4.22e-08 | 108 |
hematopoietic lineage restricted progenitor cell | 2.26e-07 | 120 |
Ontology term | p-value | n |
---|---|---|
bone marrow | 3.92e-11 | 76 |
bone element | 2.17e-10 | 82 |
skeletal element | 1.51e-09 | 90 |
immune system | 2.87e-09 | 93 |
hematopoietic system | 7.68e-09 | 98 |
blood island | 7.68e-09 | 98 |
skeletal system | 1.11e-08 | 100 |
hemolymphoid system | 4.22e-08 | 108 |